A visual safety risk evaluation tool in early clinical phases

Area of Science:

• Pharmacovigilance and Clinical Trial Safety
• Risk Management in Drug Development

Background:

• Dynamic safety risk evaluation is standard in pharmacovigilance across all clinical development stages.
• A need exists for practical tools for proactive safety risk assessment in early clinical trials.

Purpose of the Study:

• To pilot the customization of a common risk matrix for proactive safety risk evaluation in early clinical development.
• To assess the utility of a tailored visual tool for multidisciplinary safety discussions.

Main Methods:

• Customization of a common risk matrix to a specific research area.
• Application of the tailored matrix to visualize known risk profiles and projected mitigation effects.
• Development of a two-fold visualization on a single graph showing risk positioning and mitigation impact.

Main Results:

• The tailored safety risk matrix effectively visualized projected safety risk profiles and mitigation effects.
• The visual tool facilitated communication and decision-making among multidisciplinary teams in early development.
• The matrix provided a practical blueprint for teams to tailor to their specific research dimensions.

Conclusions:

• A customized visual risk matrix is a valuable tool for proactive safety risk management in early clinical development.
• The tool enhances communication and decision-making by providing clear snapshots of risk profiles and mitigation strategies.
• This approach supports the integration of practical risk assessment tools into existing pharmacovigilance processes.